News

The Malaysian Reserve6d
FDA approves updated label for Lilly’s Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer’s disease
The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to ...
Seeking Alpha6d
FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with ...
FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease Jul. 09, 2025 6:45 AM ET Eli Lilly and Company (LLY) ...
Eli Lilly and Company: FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease
The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...
Talking With Docs on MSN2d
Should You Take Daily Aspirin? | Cardiologist explains
Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble Early Rotten Tomatoes Scores For New 'Superman' Movie Are In ...
MedPage Today on MSN6d
FDA Approves Label Change for Alzheimer's Amyloid Drug
The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat ...
BioSpace6d
Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...